ERBB2 and neoplasm: In addition, a reduction in oestrogen receptor alpha (ER) expression as well as a discrepancy in ER levels between primary tumours and metastatic disease are often observed with the development of tamoxifen resistance without changes in Her2 expression (∼80% of cases)9, 10, 11.